Status:

TERMINATED

RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix

Lead Sponsor:

The George Washington University Biostatistics Center

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Preterm Delivery

Cervical Length

Eligibility:

FEMALE

Phase:

PHASE3

Brief Summary

The purpose of this study is to see if giving progesterone medication to pregnant women, who have never delivered a baby after 19 weeks of pregnancy and who have a short cervix, lowers the risk of ear...

Detailed Description

Preterm births, defined as the delivery of a baby less than 37 weeks of gestation, are responsible for the majority of neonatal mortality and morbidities. Studies have shown that a number of risk fact...

Eligibility Criteria

Inclusion

  • Nulliparous
  • Cervical length as measured on transvaginal examination \< 30mm between gestational ages of 16 weeks 0 days to 22 weeks 3 days
  • Gestational age 16 weeks 3 days to 22 weeks 6 days at time of randomization

Exclusion

  • Multifetal gestation
  • Progesterone treatment after 14 weeks 6 days during current pregnancy
  • Vaginal bleeding, heavier than spotting, after 15 weeks 6 days
  • Amniotic membranes prolapsed beyond external os
  • Preterm rupture of membranes
  • Fetal anomaly
  • Pregnancy without a viable fetus
  • Current or planned cervical cerclage
  • Congenital Mullerian abnormality of the uterus
  • Contraindication to intra-muscular injections
  • Hypertension requiring medication
  • Diabetes managed with insulin or oral hypoglycemic agents
  • DES exposure
  • Cervical surgery such as cold knife conization
  • Planned indicated preterm delivery
  • Participation in another interventional study that influences age at delivery
  • Participation in this trial in a previous pregnancy
  • Prenatal care or delivery planned outside a MFMU Network center

Key Trial Info

Start Date :

April 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

657 Patients enrolled

Trial Details

Trial ID

NCT00439374

Start Date

April 1 2007

End Date

December 1 2011

Last Update

July 15 2019

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

University of Alabama - Birmingham

Birmingham, Alabama, United States, 35429

2

Northwestern University-Prentice Hospital

Chicago, Illinois, United States, 60611

3

Dept of OB/GYN, Hutzel Hospital

Detroit, Michigan, United States, 48201

4

Columbia University-St. Luke's Hospital

New York, New York, United States, 10032